Paul Austin advocates for increased government funding of psychedelic therapy research, which can transform the way we understand and treat mental health conditions.
Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.
Andrew Fenton and L. Syd M. Johnson criticize the acceptance of non-human primate research.
Deb Mazer argues that current government policy is being driven by more than evidence.
Dalhousie researchers reply to Tim Powers and the “Harper government war on science.”